U

UZ Gent | Polikliniek - Reumatologie Department

Research site
(Unclaimed)
Location
Corneel Heymanslaan 10, Gent, East Flanders, Belgium
Site insights

Top conditions

Psoriasis (1 trial)

Left Ventricular Dysfunction (1 trial)

Melanoma (1 trial)

Heart Failure (1 trial)

Systolic Murmurs (1 trial)

Top treatments

Vericiguat
MK-6194
MK-1242-036
MK-6194-007

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of MK-6194 in participants with non-segmental vitiligo. The primary h...

Enrolling
Non-segmental Vitiligo
Drug: Placebo
Biological: MK-6194
Locations recently updated

The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid [mRNA]-...

Enrolling
Melanoma
Biological: Pembrolizumab
Biological: V940

This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline t...

Enrolling
Left Ventricular Systolic Dysfunction
Heart Failure
Drug: Vericiguat tablet
Drug: Placebo tablet

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD) (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems